Victory Capital Management Inc. Buys 37,463 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Victory Capital Management Inc. boosted its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 95.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 76,553 shares of the company's stock after acquiring an additional 37,463 shares during the period. Victory Capital Management Inc. owned 0.09% of Pediatrix Medical Group worth $1,004,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Pacer Advisors Inc. purchased a new stake in shares of Pediatrix Medical Group in the fourth quarter worth about $35,492,000. Weiss Asset Management LP lifted its stake in Pediatrix Medical Group by 50.5% during the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock worth $10,580,000 after purchasing an additional 306,143 shares during the last quarter. RBF Capital LLC bought a new stake in Pediatrix Medical Group in the 3rd quarter worth approximately $1,695,000. Rubric Capital Management LP boosted its stake in shares of Pediatrix Medical Group by 1.5% in the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock valued at $95,907,000 after purchasing an additional 125,000 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in Pediatrix Medical Group during the third quarter valued at about $1,315,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

NYSE:MD traded up $0.30 during mid-day trading on Monday, reaching $14.51. The company's stock had a trading volume of 593,809 shares, compared to its average volume of 811,255. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm's fifty day moving average price is $14.31 and its two-hundred day moving average price is $13.55. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67. The stock has a market cap of $1.25 billion, a P/E ratio of -12.09, a PEG ratio of 1.74 and a beta of 1.49.

Remove Ads

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. On average, equities analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Truist Financial upped their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research note on Friday, February 21st. UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $18.00 target price for the company. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.